We transcend borders, time zones, and especially the status quo to develop therapies that are more accessible to people around the world.

Learn More

Putting Patients First

Learn more about how we are working to discover and develop innovative medicines that are more accessible and affordable to patients around the world.

Science-Based, Passion-Driven

We are advancing an innovative, high-value product portfolio for patients globally.

Learn More
doctor_and_patient

Passion with Purpose

We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.

Learn More
people_walking

Our Commitment to Patients

We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”

Learn More
elder_women

BeiGene News

September 19, 2023

BeiGene Announces Positive Regulatory Updates in Europe and the U.S. After Recently Regaining Global Rights for TEVIMBRA®

Read more

September 19, 2023

BeiGene Strengthens Global Portfolio and Regains Full Rights from Novartis for Anti-PD-1 Antibody TEVIMBRA® (tislelizumab)

Read more

August 31, 2023

BeiGene to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

Read more

August 2, 2023

BeiGene Accelerates Global Momentum with Strong Second Quarter 2023 Financial Results

Read more

July 21, 2023

BeiGene Announces Positive CHMP Opinion for Tislelizumab as a Treatment for Advanced or Metastatic ESCC

Read more

July 12, 2023

BeiGene Announces FDA Acceptance of sNDA for Fifth BRUKINSA® Indication

Read more